New Delhi, Nov. 7 -- Sales of Eli Lilly's blockbuster weight-loss drug Mounjaro have soared in India, making it the top-selling brand in October, just six months after its launch in the world's most p... Read More
New Delhi, Nov. 6 -- Apollo Hospitals Enterprise Ltd's September-quarter financial performance beat Street expectations, as gains in its specialty care like cardiac, oncology, neurosciences, gastroent... Read More
Mumbai, Nov. 6 -- Zydus Lifesciences Ltd reported double-digit revenue and profit growth on Thursday, beating expectations for the September quarter. The Ahmedabad-based drugmaker's consolidated reve... Read More
MUMBAI, Nov. 6 -- Nandini Piramal, chairperson of Piramal Pharma, speaking to reporters on Thursday, said a rebound in US biopharma funding could boost future orders, even as the company on Wednesday ... Read More
New Delhi, Oct. 30 -- Cipla Ltd has named chief operating officer Achin Gupta its next chief executive officer and managing director, succeeding Umang Vohra, who is exiting the pharma giant after a de... Read More
New Delhi, Oct. 27 -- Indian hospital chains are expected to post steady growth in the second quarter ended September 30, a weak period compared to previous years on account of lower infection rates, ... Read More
New Delhi, Oct. 24 -- Dr Reddy's Laboratories beat street estimates in the September quarter, with a revenue of Rs.8,805 crore and profit after tax of Rs.1,437 crore, buoyed by growth in branded marke... Read More
New Delhi, Oct. 23 -- US drugmaker Eli Lilly has struck a deal with domestic drug giant Cipla Ltd to widen the reach of its blockbuster weight loss drug tirzepatide, doubling down on India's booming m... Read More
New Delhi, Oct. 22 -- Biocon Biologics Ltd is aiming to expand its insulin portfolio in the US market, as global innovators focus on more lucrative anti-obesity GLP-1 therapies. Biocon Ltd's biosimil... Read More
New Delhi, Oct. 21 -- Indian drugmakers are expected to post steady earnings growth for the quarter ended 30 September, gaining from continued traction across global markets, although domestic sales m... Read More